Welcome to the Imprimis Pharmaceuticals (NASDAQ: IMMY) investor resource site.  Imprimis was founded on the belief that all Americans deserve access to the medications they need at an affordable price.  I am privileged to lead our company as we pioneer a new pharmaceutical business model focused on making innovative and affordable compounded drugs.  Each and every day we make a difference in the lives of the customers we serve as we prove that high quality medicines can be brought to market while driving down costs. Read More >

Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today


Stay Informed

Interested in receiving investor news and updates?

Click Here

Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.

print email